| Mrs Laura Lorraine Thorpe, RPH | |
|
3840 S 103rd East Ave, Tulsa, OK 74146-2438 | |
| (918) 660-0601 | |
| Not Available |
| Full Name | Mrs Laura Lorraine Thorpe |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3840 S 103rd East Ave, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003189473 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 11630 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Laura Lorraine Thorpe, RPH 4708 E 87th Pl, Tulsa, OK 74137-2837 Ph: (918) 949-4644 | Mrs Laura Lorraine Thorpe, RPH 3840 S 103rd East Ave, Tulsa, OK 74146-2438 Ph: (918) 660-0601 |
News Archive
Boehringer Ingelheim today announced the initiation of a phase III clinical trial to investigate one of its most advanced oncology pipeline compounds, afatinib, for the treatment of patients with advanced (metastatic) breast cancer. Afatinib is an oral compound (taken as a tablet), which is a next generation, targeted therapy, that irreversibly inhibits both, the epidermal growth factor receptor (EGFR/HER1) and the human epidermal receptor HER2, which are involved in tumour growth and spread.
Serotonin receptors are common drug targets in the treatment of pain, gastrointestinal dysfunctions, and mood disorders yet little is known about their three-dimensional structure.
The delay between the time when a disease outbreak becomes possible and when it actually happens depends chiefly on how frequently infection is introduced to the population and how quickly the number of cases caused by a single individual increases, according to new research from the University of Georgia.
Sysmex America, Inc., a leading medical diagnostic instrument manufacturer and information systems developer, today announced that Laboratory Corporation of America Holdings (LabCorp) has signed a five-year agreement for Sysmex America, Inc. to provide fully automated hematology systems for LabCorp's primary testing laboratories.
New research published in the December issue of the Journal of the American College of Surgeons (JACS) suggests that surgical procedures that are shorter in duration and the use of fewer blood transfusions characterize hospitals that have a lower incidence of surgical site infections (SSI).
› Verified 5 days ago
Dr. Bradley Howard Brown, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6040 S Yale Ave, Tulsa, OK 74135 Phone: 918-494-4040 Fax: 918-496-4702 | |
Dr. Darci Marie Schwendemann, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9106 S Sheridan Rd, Tulsa, OK 74133 Phone: 918-492-3735 | |
Dr. Ted D Schwendemann, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11332 E 31st St, Tulsa, OK 74146 Phone: 918-622-9684 Fax: 918-622-6901 | |
Katie Deak, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2323 W Edison St, Tulsa, OK 74127 Phone: 918-582-1375 Fax: 918-560-9001 | |
Carter G Brashears, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1334 N Lansing Ave, Tulsa, OK 74106 Phone: 918-295-6131 | |
Mr. David Yin-lun Kwok, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10938 S Memorial Dr, Tulsa, OK 74133 Phone: 918-394-4075 Fax: 918-394-4095 |